GENEVA, June 26 -- ADLAI NORTYE BIOPHARMA CO., LTD. filed a patent application (CN2025/140511) for “IL-2 VARIANT PROTEIN AND FUSION PROTEIN THEREOF”. With publication no. WO/2026/119296, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 14/55
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....